Becton, Dickinson and Company (BDX) 은(는) 상장 기업입니다 헬스케어 섹터의 Medical - Instruments & Supplies 산업에서 운영. 본사 소재지는 Franklin Lakes, NJ, 미국. 현재 CEO는 Thomas E. Polen Jr..
BDX 을(를) 보유 IPO 날짜 1973-02-21, 70,000 명의 정규직 직원, 에 상장 NYSE, 시가총액 $56.42B.
Becton, Dickinson and Company is a global medical technology manufacturer founded in 1897 that develops and sells medical supplies, devices, laboratory equipment, and diagnostic products serving healthcare institutions, physicians, life science researchers, clinical laboratories, and pharmaceutical companies worldwide. The company operates through three primary segments: BD Medical, which provides infusion therapy systems, medication management solutions, and diabetes care products; BD Life Sciences, which offers blood collection, microbiology automation, and cellular analysis systems; and BD Interventional, which supplies surgical instruments, grafts, and critical care products. With headquarters in Franklin Lakes, New Jersey, the company delivers comprehensive solutions across medical device manufacturing, laboratory diagnostics, and clinical interventions.
